Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults

•Report of a Phase I clinical trial to assess a malaria transmission blocking vaccine.•P. falciparum Pfs25 virus-like particle produced under cGMP in a plant-based system.•The vaccine candidate displays an acceptable safety and tolerability profile.•The vaccine candidate induced Pfs25-specific IgG i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2018-09, Vol.36 (39), p.5865-5871
Hauptverfasser: Chichester, Jessica A., Green, Brian J., Jones, R. Mark, Shoji, Yoko, Miura, Kazutoyo, Long, Carole A., Lee, Cynthia K., Ockenhouse, Christian F., Morin, Merribeth J., Streatfield, Stephen J., Yusibov, Vidadi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!